The Russian Direct Investment Fund (RDIF) introduced a robot-conveyor that produces 300 COVID-19 tests per hour and does not require staff, TASS reports citing CEO of the fund, Kirill Dmitriev.
“Now we will announce some new breakthrough: our tests are in great demand at airports and other places outside the laboratories, and we will announce a robot-conveyor that can do 300 tests per hour and does not require highly qualified personnel. We believe that this will be a key decision not only for Russia, but also for other countries – to automate the passing of tests outside the laboratories, “said the general director of the fund during a meeting with Russian President Vladimir Putin.
According to Dmitriev, the RDIF has already delivered more than 15 million tests in 17 countries, including the UAE, Austria, France. The head of the RDIF also noted that the fund with partners is engaged in the production of the world’s first registered drug against COVID-19 based on the Avifavir favipiravir.
“About 300 thousand have already been delivered to Russia, we saved tens of thousands of lives. Capacities doubled to 200 thousand courses per month, and we delivered the drug to 30 countries, “he said.
Earlier, the Indonesian Drug and Food Control Agency (NADFC) issued a registration certificate for the Russian anti-COVID19 drug Avifavir (favipiravir). Since the beginning of June 2020, Avifavir has been delivered to all regions of Russia.